winner
- Akero Therapeutics, Inc. ACRO Shares rose 136.8% to $29.05 on Tuesday after the company’s Phase 2b HARMONY trial met its primary endpoint for both the 50 mg and 28 mg EFX dose groups.
- Aditxt, Inc. ADTX surged 113.8% to close at $0.37.
- Comera Life Sciences Holdings, Inc. CMRA Soared 101% to close at $3.86 after a Form 4 filing filed late Monday showed multiple insider buying of the stock.
- NeuroBo Pharmaceuticals, Inc. NRBO surged 79.3% to close at $29.90 on Tuesday as the stock traded on a 1:30 reverse split basis.
- 89bio, Inc. ETNB Shares rose 40% to close at $7.00. Analysts reportedly said that Akero’s NASH data could be positive for the company’s Pegoza program in NASH.
- Motorsport Games Inc. MSGM rose 28.1% to close at $0.97. Motorsport Games reported worse than expected Q2 EPS results last month.
- Akouos, Inc. AKUS gained 28% to close at $4.48. The FDA has approved Akouo’s Investigational New Drug application to initiate a Phase 1/2 study of AK-OTOF, a gene therapy for the otoferlin gene (OTOF) mediated hearing loss.
- Infobird Co.,Ltd IFBD rose 28% to $2.47.
- Golden Path Acquisition Corporation GPKO rose 22.4% to $8.69.
- Ensysce Biosciences, Inc. ENSC gained 22.3% to close at $0.4131.
- Immuneering Corporation IMRX rose 22.1% to close at $12.00. Immuneering recently filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its investigational product candidate IMM-1-104 for the treatment of advanced RAS mutation-positive solid tumors submitted.
- Kiora Pharmaceuticals, Inc. KPRX up 21% to close at $0.2299.
- VNET Group, Inc. vnet up 20.7% to close at $5.66 after the company announced it had received a preliminary non-binding offer to acquire all of its shares and formed a special committee to review the offer.
- Cosmos Holdings Inc. COSM rose 19.7% to $0.4216. Cosmos Health’s subsidiary SkyPharm recently launched its first Sky Premium…
